Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 10:49 am Sale | 2025-01-10 | 13G | Interpace Biosciences, Inc. IDXG | Singer Douglas Mark | 195,742 4.440% | -31,304 (-13.79%) | Filing History |
| 2025-02-14 10:46 am Purchase | 2024-12-31 | 13G | Interpace Biosciences, Inc. IDXG | Singer Douglas Mark | 227,046 5.150% | 227,046 (New Position) | Filing History |
| 2024-10-16 4:35 pm Unchanged | 2024-10-16 | 13D | Interpace Biosciences, Inc. IDXG | 1315 Capital II L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-10-16 4:30 pm Unchanged | 2024-10-16 | 13D | Interpace Biosciences, Inc. IDXG | Ampersand 2018 Limited Partnership | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-12 5:01 pm Unchanged | 2024-02-12 | 13G | Interpace Biosciences, Inc. IDXG | Singer Douglas Mark | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-10 4:23 pm Unchanged | 2023-02-10 | 13G | Interpace Biosciences, Inc. IDXG | Singer Douglas Mark | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-10 5:14 pm Unchanged | 2022-02-10 | 13G | Interpace Biosciences, Inc. IDXG | Singer Douglas Mark | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-01 10:15 am Unchanged | 2022-02-01 | 13D | Interpace Biosciences, Inc. IDXG | KAMIN PETER H | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-01-13 08:30 am Unchanged | 2022-01-13 | 13D | Interpace Biosciences, Inc. IDXG | KAMIN PETER H | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-12-06 4:32 pm Unchanged | 2021-12-06 | 13D | Interpace Biosciences, Inc. IDXG | KAMIN PETER H | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-11-12 5:21 pm Unchanged | 2021-11-12 | 13D | Interpace Biosciences, Inc. IDXG | 1315 Capital II L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-11-12 4:31 pm Unchanged | 2021-11-12 | 13D | Interpace Biosciences, Inc. IDXG | Ampersand 2018 Limited Partnership | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-05-19 5:39 pm Unchanged | 2021-05-19 | 13D | Interpace Biosciences, Inc. IDXG | 1315 Capital II L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-05-18 5:01 pm Unchanged | 2021-05-18 | 13D | Interpace Biosciences, Inc. IDXG | Ampersand 2018 Limited Partnership | 0 0.000% | 0 (Unchanged) | Filing |